Ring Christine bought NRIX
July 2, 2026 · Form 4 insider transaction
Ring Christine bought 5,221 shares of Nurix Therapeutics, Inc. at $1.86 per share, a transaction worth $9.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,221
Price
$1.86
Total value
$9.7K
InsiderRing Christine
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 2, 2026
Filing dateJuly 2, 2026
Shares owned after18,800
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.